# Phase III COBRE:  Multimodal Imaging of Neuropsychiatric Disorders (MIND)

> **NIH NIH P30** · LOVELACE BIOMEDICAL RESEARCH INSTITUTE · 2022 · $1,329,407

## Abstract

Project Summary/Abstract
 This Phase III (P-III) COBRE project will extend the cores that have been successfully leveraged in our Phase
I (P-I) and Phase II (P-II) COBRE projects and sustain these unique resources in New Mexico through the im-
plementation of a business plan. Over the past eight years we have built up infrastructure and created a cutting
edge brain imaging center, our P-II project is just over half-way through and is even more successful than our P-
I was at this point in time. The Mind Research Network (MRN) houses an Elekta Neuromag 306-channel MEG
System, a high density EEG lab, a 3T Siemens Trio MRI scanner, and a mobile 1.5T Siemens Avanto MRI
scanner. Additional resources include a centralized neuroinformatics system, a strong IT management plan, and
state-of-the-art image analysis expertise and tools. This P-III COBRE center will continue our momentum and
move the cores we have developed into a position of long term sustainability. We will continue with the technical
cores established during the P-II project including multimodal data acquisition (MDA), algorithm and data analy-
sis (ADA), and biostatistics and neuro-informatics (BNI). These cores have begun to serve MRN and the greater
community, as well as other institutions including extensive collaborations with IDeA funded projects in New
Mexico and other states. We believe this P-III COBRE is extremely well-positioned to establish and sustain New
Mexico as one of the premier brain imaging sites. We include an extensive pilot project program (PPP) that is
built on the successful pilot programs implemented as part of the earlier COBRE phases. This includes an ex-
tensive educational, mentoring, and faculty development program to carefully mentor and position faculty who
use the cores to maximize their potential to successfully compete for external funding, thus fulfilling the ultimate
goals of the COBRE program.
2

## Key facts

- **NIH application ID:** 10421418
- **Project number:** 5P30GM122734-06
- **Recipient organization:** LOVELACE BIOMEDICAL RESEARCH INSTITUTE
- **Principal Investigator:** Andrew Robert Mayer
- **Activity code:** P30 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2022
- **Award amount:** $1,329,407
- **Award type:** 5
- **Project period:** 2018-05-18 → 2025-04-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10421418

## Citation

> US National Institutes of Health, RePORTER application 10421418, Phase III COBRE:  Multimodal Imaging of Neuropsychiatric Disorders (MIND) (5P30GM122734-06). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10421418. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*